JBTM

JBT Marel Corporation 2025 Annual Report (10-K) Summary

Business Context and Reporting Period

This filing covers the fiscal year ended December 31, 2025. The reporting period is defined by the strategic acquisition of Marel hf., completed on January 2, 2025, which transformed the company into a leading global food and beverage technology solutions provider. Following the acquisition, the company changed its name to JBT Marel Corporation and its ticker symbol to JBTM. In the fourth quarter of 2025, the company realigned its reportable segments from legacy JBT and Marel to Protein Solutions and Prepared Food and Beverage Solutions.

Key Financial Metrics

Note: Liquidity is defined as cash plus borrowing ability under revolving credit facilities.

Material Changes vs. Prior Period

• Revenue Surge: Revenue more than doubled, driven primarily by the Marel acquisition which contributed $1,966.0 million. Organic revenue grew by $39.8 million, supported by a 50% recurring revenue mix.
• GAAP Net Loss: The company reported a net loss of $50.5 million compared to income of $85.4 million in 2024. This was primarily due to a $146.9 million pension settlement charge related to the termination of the U.S. qualified defined benefit plan, increased interest expense ($95.0 million increase) from debt used to fund the Marel acquisition, and M&A related costs.
• Margin Compression: Gross profit margin decreased 140 basis points to 35.1%, attributed to tariff impacts and operating inefficiencies on select projects, partially offset by synergy savings.
• Debt Increase: Total debt increased significantly to fund the Marel Transaction, including a new $900 million Term Loan B and issuance of $575 million in 2030 Convertible Senior Notes.

Guidance, Outlook, and Risks

Outlook: Management expects year-over-year revenue growth in 2026 driven by effective backlog conversion and healthy demand. The company anticipates converting 85% to 95% of the $1.372 billion order backlog into revenue during 2026. Margins are expected to improve through synergy cost savings and volume leverage.

Restructuring: The "JBT Marel 2025 Integration restructuring plan" total estimated cost was updated to a range of $55.0 million to $60.0 million, with cumulative savings expected between $65.0 million and $75.0 million.

Key Risks and Contingencies:

• Internal Control Weaknesses: Two material weaknesses in Marel's internal controls (IT general controls and journal entry review) remained unremediated as of December 31, 2025. Marel was excluded from the 2025 internal control audit assessment.
• Debt Covenants: The company is subject to leverage and interest coverage covenants. A leverage holiday allowed a maximum secured leverage ratio of 5.0x for the first 12 months post-acquisition, stepping down to 4.0x in January 2026.
• Geopolitical and Supply Chain: Risks include the impact of the Russia-Ukraine conflict on operations, inflationary pressures on raw materials, and supply chain disruptions.

Investor Verification Checklist

• Remediation of Material Weaknesses: Verify the timeline and progress for remediating the identified IT and journal entry control weaknesses at Marel to ensure future financial reporting reliability.
• Integration Synergies: Monitor the realization of the projected $65-$75 million in annualized cost savings from the integration restructuring plan.
• Debt Servicing: Assess the company's ability to service the increased debt load ($1.88 billion) and comply with the stepped-down leverage covenants starting in 2026.
• Pension Liability: Confirm the final status of the U.S. pension plan termination and ensure no further unexpected charges related to the $146.9 million settlement.
• Backlog Conversion: Track the conversion rate of the $1.372 billion order backlog against the 85-95% guidance for 2026 revenue recognition.